Marker Therapeutics, Inc. MRKR 深 滬
交易中 09-20 10:41:59 美东时间
2.899
-0.031
-1.06%
華盛通- 最 高2.92
- 今 開2.85
- 成交量 4639股
- 最 低 2.85
- 昨 收 2.93
- 總市值 2576.92万
- 52周最高 6.1568
- 市盈率 靜 --
- 換手率 0.05%
- 52周最低 2.40
- 委 比 53.85%
- 總股本 888.90万
- 歷史最高 99.00
- 量 比 2.65
- 振 幅 2.39%
- 歷史最低 2.20
- 每 手 1
- 風險率 0.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | Marker Therapeutics公司-每股季度净亏损$0.25
Marker Therapeutics Inc - Qtrly Net Loss per Share $0.25
08-15 04:32
快讯 | Marker Therapeutics报告2024年第二季度财务业绩并提供业务更新
Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides ...
08-15 04:30
Marker Therapeutics Receives $2M NIH Grant for Lymphoma Study
Marker Therapeutics (MRKR) has released an update. Marker Therapeutics has been...
08-13 00:43
快讯 | Marker Therapeutics获得NIH授予的200万美元的补助金，以支持MT-601在非何杰金（Non-Hodgkin's）淋巴瘤车T细胞复发患者中的1期研究。
Marker Therapeutics Awarded $2 Million Grant From Nih in Support of Phase 1 Stu...
08-12 19:01
Infinant Health Appoints New Team Members to assist with Drug Development
DAVIS, Calif., May 22, 2024 /PRNewswire/ -- Infinant Health, a privately-held company focused on changing the trajectory of human health by supporting the development and restoration of the ...
05-22 18:13
Marker Therapeutics’ Promising Cancer Therapy Progress
Marker Therapeutics (MRKR) has released an update. Marker Therapeutics has repo...
05-16 09:51
Marker Therapeutics(MRKR.US)：2024年Q1财报实现营收124.4万美元，前值为123.4万美元；每股收益为-0.27美元，前值为-0.57美元。
Marker Therapeutics(MRKR.US)：2024年Q1财报实现营收124.4万美元，前值为123.4万美元；每股收益为-0.27美元，前值为...
05-16 07:20
Marker Therapeutics’ MT-601 Shows Promising Results
Marker Therapeutics (MRKR) has released an update. Marker Therapeutics, Inc. ha...
04-09 00:07
Marker Therapeutics Advances in Immuno-Oncology
Marker Therapeutics (MRKR) has released an update. Marker Therapeutics has anno...
03-27 01:07
